- Home
- RGLD vs MRNA Comparison
RGLD vs MRNA Comparison
Compare RGLD & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGLD
- MRNA
- Stock Information
- Founded
- RGLD 1981
- MRNA 2010
- Country
- RGLD United States
- MRNA United States
- Employees
- RGLD N/A
- MRNA N/A
- Industry
- RGLD Precious Metals
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RGLD Industrials
- MRNA Health Care
- Exchange
- RGLD Nasdaq
- MRNA Nasdaq
- Market Cap
- RGLD 10.2B
- MRNA 10.6B
- IPO Year
- RGLD N/A
- MRNA 2018
- Fundamental
- Price
- RGLD $178.12
- MRNA $26.56
- Analyst Decision
- RGLD Buy
- MRNA Hold
- Analyst Count
- RGLD 8
- MRNA 19
- Target Price
- RGLD $181.25
- MRNA $48.13
- AVG Volume (30 Days)
- RGLD 504.3K
- MRNA 14.2M
- Earning Date
- RGLD 05-07-2025
- MRNA 05-01-2025
- Dividend Yield
- RGLD 1.01%
- MRNA N/A
- EPS Growth
- RGLD 78.68
- MRNA N/A
- EPS
- RGLD 6.04
- MRNA N/A
- Revenue
- RGLD $756,995,000.00
- MRNA $3,177,000,000.00
- Revenue This Year
- RGLD $24.99
- MRNA N/A
- Revenue Next Year
- RGLD $15.61
- MRNA $8.98
- P/E Ratio
- RGLD $29.49
- MRNA N/A
- Revenue Growth
- RGLD 31.09
- MRNA N/A
- 52 Week Low
- RGLD $119.72
- MRNA $23.15
- 52 Week High
- RGLD $191.78
- MRNA $158.82
- Technical
- Relative Strength Index (RSI)
- RGLD 52.78
- MRNA 50.60
- Support Level
- RGLD $175.34
- MRNA $25.22
- Resistance Level
- RGLD $180.56
- MRNA $27.15
- Average True Range (ATR)
- RGLD 3.85
- MRNA 1.61
- MACD
- RGLD 0.06
- MRNA 0.26
- Stochastic Oscillator
- RGLD 79.59
- MRNA 47.66
About RGLD Royal Gold Inc.
Royal Gold Inc enquires and manages precious metal royalties and streams, with a focus on gold. The company operates by purchasing a percentage of the metal produced from a mineral property for an initial payment, without assuming responsibility of mining operations. Similarly, precious metal streams are purchase agreements with mine operators providing the right to purchase all or a portion of one or more metals produced from a mine, in exchange for an upfront deposit payment. Generally Royal Gold does not conduct any work on the properties in which it holds royalty and streaming assets. The company owns a portfolio of producing, development, evaluation, and exploration royalties and streams, and the majority of group revenue is generated from Canada, Mexico, Chile, and the United States.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.